Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Abstract:
The authors discuss clinical findings on whether antiarrhythmic drug choice in patients with left ventricular hypertrophy (LVH) should be limited, citing the retrospective analysis of patients with atrial fibrillation and LVH published in the issue. Topics covered include the basis of the concern over the use of class III antiarrhythmic drugs in patients with LVH, the association of amiodarone with lower survival and he need for antiarrhythmic choice to follow guideline recommendations.
No Comments.